Contributions of KPV_Kester
User contributions·12 logged edits·page 1 of 1
Contributions by KPV_Kester, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,055 edits includes activity predating the current log.
- 22:58, 14 Jul 2026 (diff | hist) Melanotan II 4,649 ±0 attribute the half-life to the species it was measured in
- 09:19, 18 Jun 2026 (diff | hist) Test report forgery 5,391 ±0 m give the fields a compendially-complete certificate would carry
- 00:33, 13 Jun 2026 (diff | hist) Sigma-Aldrich (Shanghai) Trading 18,641 ±0 split §Operations from §Product range
- 18:19, 3 Mar 2026 (diff | hist) Amylin 5,795 ±0 rm duplicated pharmacokinetics — the same figures appear in the infobox
- 14:00, 2 Feb 2026 (diff | hist) Placebo-adjusted effect 4,805 ±0 expand §How figures are misreported
- 13:14, 30 Jan 2026 (diff | hist) Glossary of peptide terminology 4,744 ±0 rm an entry that does not meet the stated inclusion criterion
- 05:53, 19 Dec 2025 (diff | hist) PeptideMeter 4,925 ±0 add the note that self-submitted reports are a self-selected sample
- 08:16, 18 Aug 2025 (diff | hist) SURPASS trial programme 5,078 ±0 expand §The head-to-head comparison
- 22:40, 26 Feb 2025 (diff | hist) Growth hormone secretagogue 3,433 +83 m rm the aggregate purity claim — no source, and no such survey exists
- 20:29, 4 Nov 2024 (diff | hist) Weight regain after discontinuation 2,822 ±0 add the time course: most of these events are early and transient
- 07:34, 15 Oct 2024 (diff | hist) SELECT trial 2,782 +454 split overlong sentence
- 23:53, 18 Sep 2024 (diff | hist) Nantong Guangyuan Chemical 5,037 +747 clarify that a registered business scope is a licensing fact, not a quality assurance